In a first-ever analysis, the Access to Medicine Foundation looked at the approaches 20 leading drug companies are taking to determine how many patients actually access their products. Read more.
Foreign Correspondent
In a first-ever analysis, the Access to Medicine Foundation looked at the approaches 20 leading drug companies are taking to determine how many patients actually access their products. Read more.